Traditional uses, medicinal properties, and phytopharmacology of Ficus racemosa: a review by Ahmed, F. & Asna Urooj
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=iphb20
Pharmaceutical Biology
ISSN: 1388-0209 (Print) 1744-5116 (Online) Journal homepage: https://www.tandfonline.com/loi/iphb20
Traditional uses, medicinal properties, and
phytopharmacology of Ficus racemosa: A review
Faiyaz Ahmed & Asna Urooj
To cite this article: Faiyaz Ahmed & Asna Urooj (2010) Traditional uses, medicinal properties, and
phytopharmacology of Ficus￿racemosa: A review, Pharmaceutical Biology, 48:6, 672-681, DOI:
10.3109/13880200903241861
To link to this article:  https://doi.org/10.3109/13880200903241861
Published online: 06 May 2010.
Submit your article to this journal 
Article views: 5390
Citing articles: 10 View citing articles 
Introduction
Medicinal plants, since times immemorial, have been 
used in virtually all cultures as a source of medicine. 
The widespread use of herbal remedies and healthcare 
preparations, as those described in ancient texts such 
as the Vedas and the Bible, and obtained from com-
monly used traditional herbs and medicinal plants, has 
been traced to the occurrence of natural products with 
medicinal properties (Hoareau & DaSilva, 1999). The 
use of traditional medicine and medicinal plants in most 
developing countries, as a normative basis for the main-
tenance of good health, has also been widely observed 
(UNESCO, 1996). Furthermore, an increasing reliance 
on the use of medicinal plants in industrialized societies 
has been traced to the extraction and development of 
several drugs and chemotherapeutics from these plants 
as well as from traditionally used rural herbal rem-
edies (UNESCO, 1998). The World Health Organization 
has estimated that 80% of the world’s population use 
botanical medicine for their primary health care needs 
(Akerele, 1993).
Ficus racemosa Linn. (Moraceae) is an evergreen, 
moderate to large-sized spreading, lactiferous, deciduous 
tree 15-18 m high, without prominent aerial roots (Varier, 
1995). Ficus is an exceptionally large pan-tropical genus 
with over 700 species (Berg, 1989) distributed widely 
throughout the warmer parts of Asia, Africa, America, 
and Australia. It is retained as a single, large genus 
because it is well defined by its unique reproductive sys-
tem, involving synconia fig and specialized pollinator 
wasps (Novotny et al., 2002). F. racemosa is commonly 
known as ‘gular’, and all parts of this plant are regarded 
medicinally important in Ayurveda and it has been used 
extensively in the treatment of biliary disorders, jaun-
dice, dysentery, diabetes, diarrhea and inflammatory 
conditions (Kirtikar & Basu, 1975; Nadkarni et al., 1976; 
Chopra et al., 1958).
In this review a comprehensive account of the mor-
phology, phytochemical constituents, traditional uses, 
and pharmacological activities are included in view of 
the many recent findings of importance on this plant.
Taxonomy of Ficus racemosa
Kingdom: Plantae, Planta, Planter, Plants, Vegetal; Sub 
Kingdom: Tracheobionta, Vascular Plants; Division: 
Magnoliophyta; Superdivision: Spermatophyta; Class: 
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Ficus racemosa Linn. (Moraceae) is a popular medicinal plant in India, which has long been used in 
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Magnoliopsida; Subclass: Hamamelididae; Order: 
Urticales; Family: Moraceae; Genus:Ficus L.
Synonyms
Covellia glomerata (Roxb.) Miq., Ficus glomerata Roxb., 
Ficus vesca F.Muell. ex Miq., and Ficus semicostata 
F.M.Bailey (DMP, 1982).
Common names
Gular fig, cluster fig, country fig and redwood fig (Joy 
et al., 2001).
Vernacular names
English: Cluster fig, Country fig, Redwood fig; Chinese: Ju 
Guo Rong; Burmese: Jagyadumbar; Hindi: Gular; Urdu: 
Dimiri; Sanskrit: Udumbara; Kannada: Atti; Bengali: 
Dumur; Tamil: Atti (DMP, 1982; Kunwar & Bussmann, 
2006).
Distribution
F. racemosa is not epiphytic but is found throughout 
greater part of India in moist localities, along the banks 
of streams, sides of ravines and also on rocky slopes, 
sometimes almost gregariously. It is also found in Burma, 
China, Indonesia, Malaysia, and Australia (DMP, 1982). 
It is often cultivated round villages in India for its edible 
fruits (CSIR, 1952).
Morphology
F. racemosa is an evergreen, moderate to large, spread-
ing, lactiferous, deciduous tree (Figure 1), 15-18 m high, 
without prominent aerial roots (Varier, 1995). Young 
shoots are glabrous, pubescent or scaberulous, leaves 
are dark green colored, 7.5-15 by 3.2-6.3 cm, ovate 
oblong, or elliptic-lanceolate, tapering to a bluntish 
point at the apex, with entire margins, glabrous on both 
surfaces when mature, base acute or rounded, 3-nerved; 
lateral main nerves 4-6 pairs; petioles 1.3-3.8 cm long, 
glabrous; stipules 2 cm long, ovate-lanceolate, scarious, 
pubescent; fruit receptacles 2-5 cm in diameter, subglo-
bose or pyriform, found in large clusters on short leaf-
less branches arising from main trunk or large branches 
(Figure 2).
Figs are smooth or pubescent and rarely covered 
with minute soft hairs. When ripe, they are orange, 
dull reddish or dark crimson (Figure 3) with depressed 
umbilicus (edible but usually full of worms); basal 
bracts 3, ovate-triangular; male, female, and gall 
flowers together in one receptacle, the male flowers 
forming a layer near the walls of the receptacle, and 
the gall flowers a more internal layer; male flowers 
sessile; sepals 3-4, membranous, inflated, enveloping 
the 2 elongate ovate anthers; filaments connate; gall 
flowers pedicellate; perianth gamophyllous, irregularly 
toothed, covering only the base of the rough ovoid 
ovary; style lateral, elongate; stigma clavate; fertile 
flowers subsessile; perianth gamophyllus, with 4 or 5 
long lanceolate teeth enveloping the small minutely 
tuberculate achene; style sub-terminal; stigma clavate 
(Kirtikar & Basu, 1975).
The fruits, borne in great profusion, mature generally 
from March to July. When fully ripe, they have a pleasant 
Figure 1. Ficus racemosa tree.
Figure 2. Unripe fruits of Ficus racemosa.
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odor, resembling that of cider apples. Often they are full 
of maggots of the fertilizing wasp and unfit for eating 
(CSIR, 1952). The bark is astringent, rusty brown with 
a fairly smooth and soft surface, the thickness varies 
from 0.5-2 cm according to the age of the trunk or bark, 
surface with minute separating flakes of whitish tissue, 
texture homogenous leathery (Varier, 1995).
Traditional uses
F. racemosa, which has been reported to have many 
medicinal properties, is widely cultivated all over India 
(Trivedi et al., 1969). Different parts of the plant are 
traditionally used as fodder (CSIR. 1952), edible and 
ceremonial (Manandhar, 1972; DMP, 1982; Dhakal & 
Aizz, 1996; Chaudhary et al., 1999; Pathak, 2000; Sah 
et al., 2002; Manandhar & Acharya, 2003). All parts of 
this plant (leaves, fruits, bark, latex, and sap of the root) 
are medicinally important in the traditional system of 
medicine in India (Kirtikar & Basu, 1975).
Leaves
A mixture of leaves powdered with honey is used in 
 bilious infections (Kirtikar & Basu, 1975). A decoction of 
leaves is used as a douche in dysmenorrhea (Nadkarni 
et al., 1976), as a wash for wounds and ulcers. Leaf juice 
is massaged on hair to prevent splitting. Leaf latex is used 
for boils and blisters and measles (Siwakoti & Siwakoti, 
2000).
Fruits
The fruit is an astringent, stomachic, carminative given 
in menorrhea and hemoptysis (Chopra et al., 1958). 
Fruits are used as a remedy for visceral obstruction, 
diarrhea and constipation (Vihari, 1995). A bath made of 
fruit and bark is regarded as a cure for leprosy. The fruit 
is regarded as a good remedy for diabetes (Nadkarni 
et al., 1976).
Bark
The bark is astringent. An infusion of bark is employed 
as mouth wash in spongy gum condition, dysentery, 
menorrhea, hemoptysis, and diabetes (Chopra et al., 
1958). It is also used as a wash for wounds, highly effica-
cious in threatened abortions and also recommended 
in uropathy. A decoction of bark is given in asthma and 
piles (Kirtikar & Basu, 1975). The sap extracted from 
the trunk has been described as valuable medicine in 
diabetes. Paste of stem bark is used in burns, swelling, 
leucorrhea (Paudyal, 2000) dysentery and diarrhea 
(Tiwari, 2001).
Latex
The latex is aphrodisiac and is administered in boils, 
diarrhea, dysentery, and hemorrhoids (Yadav, 1999). 
It is also used to cure stomachache (Ghimire et al., 
2000), cholera and mumps (Basnet, 1998). It has been 
reported in the indigenous system of medicine in Sri 
Lanka in the treatment of skeletal fracture (Ekanayake, 
1980) to control severe diarrhea, particularly in children 
(Bheemachari et al, 2007). Latex is used as adhesive 
(Dangol, 2002).
Sap of the root
Sap of the root is given for gonorrhea, diabetes and as 
a topical application in mumps and other inflammatory 
glandular enlargements (Chopra et al., 1958). Root sap is 
claimed to cure heat stroke, chronic wounds and malaria 
in cattle (Thapa, 2001).
Phytochemistry
The leaves contain triterpenoids (Mandal et al., 1999) 
tannins, kaempferol, rutin, arabinose, bergapten, pso-
ralenes, flavonoids, ficusin, coumarin, phenolic gly-
cosides (Baruah & Gohain, 1992; Deraniyagala et al., 
1998) and saponins (Din et al., 2002). Fruits are reported 
to contain sterols, triterpenoids, flavonoids, glyco-
sides, tannins, carbohydrates (Deshmukh et al., 2007), 
β-sitosterol, gluanol acetate, hentriacontane, tiglic acid 
Figure 3. Ripe fruits of Ficus racemosa.
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of taraxasterol, lupeol acetate (Singhal & Saharia, 1980; 
Nguyen et al., 2001; Chandra et al., 1979; Merchant 
et al., 1979), gallic acid, ellagic acid (Rao et al., 2008) 
and α-amyrin acetate (Narender et al., 2008). Stem bark 
contains steroids, alkaloids, tannins (Rao et al., 2002a), 
gluanol acetate,  leucocyanidin-3-O-β-D-glucopyranc
oside, leucopelargonidin-3-O-β-D-glucopyranoside, 
leucopelargonidin-3-O-α-L-rhamnopyranoside, 
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Figure 4. Structures of phytochemicals identified and isolated from various parts of Ficus racemosa.
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ceryl behenate, lupeol acetate, α-amyrin acetate (Joy 
et al., 2001), lupeol (Balas & Agha, 1985; Singhal & 
Saharia, 1980; Nguyen et al., 2001), friedelin, behanate 
(Malairajan et al., 2006), stigmasterol (Singhal & Saharia, 
1980), β-sitosterol, β-sitosterol-D-glucoside (Singhal & 
Saharia, 1980; Nguyen et al., 2001; Chandra et al., 1979; 
Balas & Agha, 1985), gluanol acetate (Rahuman et al., 
2008), and quercetin (Khan & Sultana, 2005a). Bergenin, 
racemosic acid, (Veerapur et al., 2007; Li et al., 2004) 
friedelin (Balas & Agha, 1985), β-sitosterol, β-amyrin, 
and lupeol acetate (Rahman et al., 1994) have been iso-
lated from the bark of F. racemosa (Figure 4, A-Q).
Biological activities
Hypoglycemic/antihyperglycemic activity
Antidiabetic potential of various parts of F. racemosa 
has been evaluated in alloxan/streptozotocin-induced 
 diabetic rats/rabbits. Aqueous extract equivalent to 15 g 
of F. racemosa bark powder decreased blood glucose 
to an extent of 13.3%; 18.8% at 18 h and 48 h fasting 
 intervals in normoglycemic rabbits and 6%; 17% in dia-
betic  rabbits (Shrotri & Aiman, 1960).
Aqueous and ethanol extracts of the stem bark (300 
and 400 mg/kg body weight) exhibited prominent 
long-term antihyperglycemic effect by reducing the 
blood glucose to an extent of 80% in alloxan-induced 
diabetic rats. The hypoglycemic effect of ethanol 
extract was comparable with that of glibenclamide 
(Vasudevan et al., 2007). The extracts significantly 
increased the plasma insulin levels and inhibited 
the activity of glucose 6-phosphatase and hexoki-
nase. Ethanol extract of F. racemosa bark (300 mg/kg 
body weight) reduced the blood glucose, serum lipids 
and lipoproteins to near normal range and these effects 
were comparable with that of the standard antidiabetic 
drug-glibenclamide (Sophia & Manoharan, 2007). 
Similarly, methanol extract of the stem bark at doses of 
200 and 400 mg/kg exhibited significant hypoglycemic 
effect in both normal and alloxan-induced diabetic 
rats, comparable to that of glibenclamide (10 mg/kg), 
a standard antidiabetic agent (Rao et al., 2002b). In 
another study, petroleum ether extract of the fruits 
(200 mg/kg) exhibited a significant anti-hyperglycemic 
activity in alloxan-induced diabetic mice (Deshmukh 
et al., 2007) and oral doses of petroleum ether extract 
(250 mg/kg) significantly lowered blood sugar, serum 
cholesterol, serum urea and serum triglyceride levels in 
alloxan-induced diabetic treated rats and the hypogly-
cemic effects were compared with those of glibencla-
mide (Patil et al., 2006). α-Amyrin acetate (100 mg/kg) 
isolated from the fruits of F. racemosa lowered the blood 
glucose by 18.4% and 17.0% at 5 and 24 h, respectively, 
in sucrose challenged streptozotocin-induced diabetic 
rat model (Narender et al., 2008).
A compound recipe of medicinal plants containing 
F. racemosa leaves as an ingredient showed a significant 
hypoglycemic effect and increased serum insulin levels 
significantly in alloxan-induced diabetic rabbits. The 
study indicated that the increase in serum insulin levels 
of diabetic rabbits was due to the regeneration of some 
of the pancreatic β-cells (Wadood et al., 2007). The com-
pound recipe did not show acute toxicity nor resulted 
in any behavioral changes. Kar et al. (2003) reported 
oral feeding of ethanol extract of the root (500 mg/
kg) caused a significant decrease in blood glucose in 
alloxan-induced diabetic rats. The herbal formulation 
D-400 containing F. racemosa as an ingredient showed 
a significant hypoglycemic activity and effectively 
decreased renal damage in alloxan-induced diabetic 
rabbits (Benny & Adithan, 2000). In an acute study 
petroleum ether extract of the leaves at the levels of 200 
and 400 mg/kg decreased blood glucose to an extent of 
29% and 35%, respectively, in streptozotocin induced 
diabetic rats (Mandal et al., 1997a). Similar observations 
are reported by Patil et al. (2009) at a dose of 300 mg/
kg. The 95% ethanol extract decreased blood glucose by 
50% in streptozotocin induced diabetic rats (Patil et al., 
2009).
The petroleum ether extract of stem bark decreased 
blood glucose by 16% and 62%, fruits by 11% and 20%, 
and the latex by 7% and 8%, respectively, in normal 
and diabetic rats. The results suggested that most of the 
hypoglycemic principles are present in the stem bark of 
F. racemosa. Further, the stem bark extract effectively 
inhibited glucose 6-phosphatase and arginase in vitro 
(Rahman et al., 1994).
Antioxidant and radioprotective activity
Herbal radioprotectors have been gaining prime impor-
tance in radioprotective drug discovery due to lesser side 
effects as reviewed extensively by many authors (Arora 
et al., 2005; Meenal et al., 2006). The damage to DNA and 
membrane lipids is a critical factor in radiation-induced 
cellular damage and reproductive cell death. The etha-
nol extract of F. racemosa stem bark showed a significant 
free radical scavenging activity in a dose-dependent 
manner. Such free radical scavengers exert a key role in 
radio-protection, because radiation-induced cytotoxic-
ity is mediated mainly through generation of free radi-
cals in the biological system (Breen & Murphy, 1995).
Sharma and Gupta (2008) investigated the anti-
oxidant activity of ethyl acetate extract of the root and 
the results indicate that the extract possesses potent 
antioxidant activity and is mediated through free radi-
cal scavenging, reducing power and hydrogen peroxide 
scavenging activity. Preliminary phytochemical analysis 
and β-carotene linoleate oxidation models indicates 
the presence of polyphenols (tannins, flavonoids) in 
the extract and the antioxidant potential of the extract 
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may be due to the presence of phenolic compounds. 
Racemosic acid isolated from the ethanol extract of 
F. racemosa bark exhibited a strong radical scavenging 
activity comparable to that of Trolox, a synthetic anti-
oxidant (Li et al., 2004). Aqueous and ethanol extract of 
F. racemosa stem bark exhibited significant antioxidant 
activity in alloxan-induced diabetic rats and significantly 
improved the antioxidant status by decreasing TBARS 
content and increasing GSH levels and other enzymatic 
antioxidant defense systems (Vasudevan et al., 2007).
Methanol and 70% acetone extracts of F. racemosa 
stem bark exhibited dose-dependent reducing power 
activity and the methanol extract exhibited more hydro-
gen donating ability. Similar dose-dependent activity 
was seen in DPPH• and •OH scavenging systems. Both 
the extracts exhibited antioxidant activity against the 
linoleic acid emulsion system and the potential of mul-
tiple antioxidant activity was evident as it possessed 
antihemolytic activity and metal ion chelating potency 
(Manian et al., 2008). Channabasavaraj et al. (2008) 
reported the methanol extract of the bark to exhibit 
potent antioxidant activity in vitro.
Hepatoprotective activity
The hepatoprotective activity of petroleum ether extract 
of F. racemosa leaves was evaluated in carbon tetrachlo-
ride/paracetamol-induced chronic liver damage. Oral 
administration of the leaf extract (400 mg/kg) exhibited 
a significant reduction in the levels of SGOT, SGPT, alka-
line phosphatase and serum bilirubin. The activity of the 
extract was comparable with that of Neutrosec (a stand-
ard liver tonic). Further, 3.95% mortality was observed in 
the CCl
4
 treated group and autopsy showed congested 
and enlarged liver, sometimes associated with intestinal 
bleeding and inflammation. However, no mortality was 
observed in extract-treated groups (Mandal et al., 1999). 
The extract also exhibited a significant hepatoprotective 
effect comparable to that of Neutrosec in paracetamol-
induced hepatotoxity (Mandal et al., 1999).
The methanol extract of the bark when given orally 
along with CCl
4
 at the doses of 250 and 500 mg/kg body 
weight (bw) showed a significant hepatoprotection as 
evident by the reversal of increased serum transami-
nases comparable to that of silymarin histological 
changes (Channabasavaraj et al., 2008).
Chemopreventive activity
Treatment of rats orally with F. racemosa extract (200 
and 400 mg/kg bw) resulted in significant decrease in 
γ-glutamyl transpeptidase, lipid peroxidation, xanthine 
oxidase, H
2
O
2
 generation, blood urea nitrogen, serum 
creatinine, renal ODC activity, DNA synthesis (Pb 
0.001) and incidence of tumors in ferric nitrilotriacetate 
(Fe-NTA)-induced chemotoxicity in rats. Renal glutath-
ione content, glutathione metabolizing enzymes and 
antioxidant enzymes were also restored suggesting F. 
racemosa extract to be a potent chemopreventive agent 
(Khan & Sultana, 2005a).
Oral treatment of rats with F. racemosa extract (200 
and 400 mg/kg BW) resulted in a significant decrease 
in xanthine oxidase, γ-glutamyl transpeptidase activi-
ties, lipid peroxidation and H
2
O
2
. A significant recovery 
of renal glutathione and antioxidant enzymes was also 
reported. There was also reversal in the enhancement of 
renal ornithine decarboxylase activity, DNA synthesis, 
blood urea nitrogen and serum creatinine indicating 
F. racemosa extract to be a potent chemopreventive 
agent and suppressing potassium bromate-induced 
nephrotoxicity in rats (Khan & Sultana, 2005b).
Anti-inflammatory activity
Anti-inflammatory activity of F. racemosa has been 
evaluated in several studies. The petroleum ether 
extract of the leaves effectively suppressed the inflam-
mation produced by histamine and serotonin and the 
anti-inflammatory activity was attributed for the anti-
serotonin activity of the extract. The extract also reduced 
the edema, produced by dextran which is known to be 
mediated both by histamine and serotonin (Ghosh et al., 
1963). The extract exhibited significant anti-inflamma-
tory activity in the cotton pellet test reflecting its efficacy 
to reduce an increase in the number of fibroblasts and 
synthesis of collagen and mucopolysaccharide which 
are natural proliferative events of granulation tissue for-
mation (Arrigoni-Martellie, 1977).
The ethanol extract of the bark, frozen fruits and the 
milky sap as such exhibited significant anti- inflammatory 
activity in vitro as reflected by the inhibition of COX-1 to 
an extent of 89%, 71%, and 41%, respectively, at 3.4 mg/
mL concentration (Li et al., 2003). In another study, the 
ethanol extract of the bark showed a significant inhibi-
tion of COX-1, 5LOX and phospholipase A
2
 (PA
2
). The 
extract effectively inhibited the biosynthesis of PGE
2
, 
PGD
2
 in COX-1 assay and the formation of 5HETE in 
5LOX assay (Li et al., 2004).
The petroleum ether extract of F. racemosa leaves at 
doses of 200-400 mg/kg bw exhibited significant anti-
inflammatory activity in carrageenan-, serotonin-, 
histamine- and dextran-induced rat hind limb paw 
edema. A maximum effect was observed at 400 mg/kg 
dose. In chronic tests, at 400 mg/kg the effect was com-
parable with that of phenylbutazone, a non-steroidal 
anti- inflammatory agent (Mandal et al., 2000).
Analgesic activity
Analgesic activities of ethanol extracts of the bark 
and leaves were evaluated using hot-plate and tail- 
immersion methods. At 300 mg/kg, i.p., F. racemosa leaf 
extract increased the latency time significantly, giving 
about 40.1% protection; the bark extract increased the 
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reaction time significantly providing 35% protection. 
The observed analgesic effect was attributed to the pres-
ence of friedelin, behanate, bergenin, lupeol and lupeol 
acetate (Malairajan et al., 2006).
The decoction of F. racemosa leaves produced a sig-
nificant decrease in the number of writhes in the acetic 
acid writhing test in mouse. A similar effect was seen 
in the hot-plate test where a significant analgesic activ-
ity was observed which continued until 3 h after the 
administration of the decoction in mice. A significant 
anti-edemic effect was exhibited by the petroleum ether 
extract in carrageenan-induced paw edema in mice 
(Forestieri et al., 1996).
Antibacterial/antifungal activity
A number of studies have reported the antibacterial 
potential of F. racemosa against different bacterial 
strains. Stem bark ethanol extract was found to be very 
effective against Pseudomonas aeruginosa, Proteus 
mirabilis, Staphylococcus aureus, Bacillus cereus, 
Alcaligenes faecalis, and Salmonella typhimurium bac-
terial strains, indicating the scope to discover bioactive 
natural products that may serve as leads in the develop-
ment of new pharmaceuticals in order to address unmet 
therapeutic needs (Nair & Chanda, 2007). In another 
study the same authors reported that the ethanol extract 
of stem bark exhibited significant antibacterial activity 
against Pseudomonas aeruginosa, Proteus mirabilis, 
and Bacillus cereus bacterial strains, while the aque-
ous extract inhibited Streptococcus faecalis significantly 
(Nair & Chanda, 2006) and the methanol extract exhib-
ited significant antibacterial activity against Bacillus 
subtilis (Mahato & Chaudhary, 2005).
Mandal et al. (2000) evaluated various extracts of 
F. racemosa leaves for antibacterial potential against 
Escherichia coli, Bacillus pumilus, Bacillus subtilis, 
Pseudomonas aeruginosa, and Staphylococcus aureus. 
It was found that the petroleum ether extract was most 
effective against the tested organisms and the effect 
produced was significant and was compared with chlo-
ramphenicol, a known antibiotic, supporting the use 
of F. racemosa for treating dysentery and diarrhea in 
the traditional system of medicine. The 50% methylene 
chloride in hexane flash column fraction of the extract of 
the leaves of F. racemosa effectively inhibited the growth 
of Curvularia sp., Colletotrichum gloeosporioides, 
Alternaria sp., Corynespora cassiicola, and Fusarium sp. 
(Deraniyagala et al., 1998).
Gastroprotective activity
Ethanol extract (50%) of the fruits showed dose-
 dependent inhibition of ulcer index in pylorus ligation, 
ethanol and cold resistant stress-induced ulcers. The 
extract also protected the gastric mucosa by inhibit-
ing lipid peroxidation and superoxide dismutase, H+ 
K+ ATPase and increased the activity of catalase (Rao 
et al., 2008).
The ethanol extracts of F. racemosa bark and leaves 
attenuated the gastric volume free acidity total acid-
ity ulcer index in aspirin plus pylorus ligation-induced 
gastric ulcer in rats and also reduced the gastric lesion 
induced by HCl-ethanol mixture and showed protec-
tion against water immersion stress-induced ulcers 
(Malairajan et al., 2007). Anti-ulcerogenic effect of 50% 
ethanol extract of unripe fruits of F. racemosa (100, 200, 
and 300 mg/kg) was studied in ethanol 4 h pylorus liga-
tion-induced gastric ulcer in rats. The extract produced 
significant antiulcer activity at all the doses studied and 
the effect at 300 mg/kg dosage was comparable with that 
of sucralfate (250 mg/kg) (Sangameswaran et al., 2008). 
Similar antiulcer effect comparable with that of sucral-
fate was exhibited by the methanol extract of unripe 
fruits of F. racemosa (100, 200, and 400 mg/kg) in gastric 
ulcer models induced by aspirin and cold restraint stress 
(Sangameswaran et al., 2007).
Antidiarrheal activity
Methanol extract of the bark has shown a significant 
antidiarrheal effect in castor oil-induced diarrhea and 
PGE2-induced enteropooling in rats. The extract also 
exhibited a significant reduction in gastrointestinal 
motility in charcoal meal test in rats (Mukherjee et al., 
1998). Mandal et al. (1997b) reported similar observa-
tions by the petroleum ether extract of F. racemosa leaves 
in rats. The latex exhibited significant inhibitory activity 
against castor oil-induced diarrhea and enteropooling 
in latex-treated rats and also reduced gastrointestinal 
motility following charcoal meal in rats (Bheemachari 
et al., 2007).
Antifilarial activity
Alcoholic and aqueous extracts of the fruits of 
F. racemosa caused inhibition of spontaneous motility 
of whole worm and nerve muscle preparation of Setaria 
cervi characterized by increase in amplitude and tone 
of contractions. The concentrations required to inhibit 
the movement of the whole worm and nerve muscle 
preparation for alcohol extract were 250 and 50 µg/mL, 
respectively, while, for aqueous extract it was 350 and 
150 µg/mL, respectively. Both alcohol and aqueous 
extracts caused death of microfilariae in vitro. LC
50
 
was 21 and 27 ng/mL and LC
90
 was 35 and 42 ng/mL, 
respectively, for alcohol and aqueous extracts (Mishra 
et al., 2005).
Larvicidal/wormicidal activity
Rahuman et al. (2008) evaluated the larvicidal activ-
ity of hexane, ethyl acetate, petroleum ether, ace-
tone, and methanol extracts of the leaf and bark of 
F. racemosa against the early fourth instar larvae of 
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Culex  quinquefasciatus. The larval mortality was 
observed after 24 h exposure and all the extracts showed 
moderate larvicidal effects but the acetone extract of 
the bark showed highest larval mortality. The larvicidal 
activity of F. racemosa was attributed to the presence 
of gluanol acetate which was also found to be very 
potent against fourth instar larvae of Aedes aegypti L., 
Anopheles stephensi L., and C. quinquefasciatus Say.
The crude extracts of Ficus racemosa bark (petroleum 
ether, chloroform, ethanol and water) evaluated for 
anthelmintic activity using adult earthworms exhibited 
a dose-dependent inhibition of spontaneous motility 
(paralysis) and evoked responses to pin-prick. Higher 
doses of aqueous extract (50 mg/mL) caused irreversible 
paralysis indicating the wormicidal activity of the extract 
(Chandrashekhar et al., 2008).
Antipyretic activity
The methanol extract of the bark given at a dose of 200 
and 300 mg/kg bw showed a significant dose-dependent 
reduction in body temperature in both normal and 
yeast-induced pyrexia in albino rats. The antipyretic 
effect of the extract was comparable to that of paraceta-
mol (150 mg/kg bw) a standard antipyretic drug (Rao et 
al., 2002a). The decoction and petroleum ether extract 
of the leaves manifested a significant antipyretic effect 
comparable to that of indomethacin against yeast-in-
duced pyrexia in rats (Forestieri et al., 1996).
Antitussive activity
The antitussive potential of the methanol extract of the 
bark was evaluated in sulfur dioxide gas-induced cough 
in mice. The extract demonstrated significant antitus-
sive activity comparable to that of codeine phosphate 
(10 mg) a standard antitussive agent. Maximum activity 
was attained at 200 mg/kg bw at 90 min after administra-
tion of the extract (Rao et al., 2003).
Hypotensive activity
The leaves of F. racemosa extracted with various solvents 
and the fraction rich in glycosides exhibited significant 
hypotensive and vasodilator effect on anesthetized dogs 
and direct cardiac depressant action on isolated hearts 
of frog and rabbit. The extract did not affect the behavio-
ral activity and did not show signs of acute toxicity in rats 
(Trivedi et al., 1969).
Wound healing property
The wound healing property of F. racemosa is mentioned 
in different Ayurvedic texts and in a research study the 
ointment prepared from the powder of the leaves with 
petroleum jelly (15% w/w) in an 8 mm full-thickness 
punch wound rat model showed highly significant 
 generation of tissue DNA (1.73 mg/g), RNA (1.17 mg/g), 
and total protein (16.62 mg/g) during the healing  process 
in comparison with untreated control rats (Biswas & 
Mukherjee, 2003).
Toxicity studies
Li et al. (2004) evaluated the cytotoxic effect of ethanol 
extracts of F. racemosa bark using ATP-based lumines-
cence assay in human skin fibroblasts (1BR3), human 
hepatocytes carcinoma (HEPG2) and human promy-
elocytic leukemia (HL-60) of cell density 1 x 104 cells/
mL. The extract showed IC
50
 values of 1.79, 0.098, and 
1.69 mg/mL, respectively, which were significantly lower 
than that of aspirin and mercuric chloride. The extract 
was significantly less toxic than aspirin and mercuric 
chloride after 48 h of exposure of the cell lines tested.
The water/hydro-alcohol/alcohol extracts of the bark 
showed a LC
50
 of 850 µg/mL in brine shrimp lethality test, 
rendering it non-toxic and representing its safety in its 
usage in traditional medicine (Krishnaraju et al., 2006). 
The acute toxicity of methanol extract of the stem bark of 
F. racemosa was evaluated in Albino mice and the study 
established that the extract is safe even at a higher dose 
of 3.2 g/kg (Rao et al., 2002b), while the petroleum ether 
extract of F. racemosa fruits did not produce toxicity 
even at a dose of 5 g/kg in mice (Deshmukh et al., 2007). 
Rao et al. (2008) reported that the hydro-ethanol extract 
(50%) of fruits is non-toxic and safe, as no mortality or 
change in behavioral pattern was observed in mice. The 
leaf extract also did not affect the behavioral activity and 
did not show signs of acute toxicity in rats (Trivedi et al., 
1969). Forestieri et al. (1996) reported a LD
50
 value >10 g/
kg bw for petroleum ether and ethanol extracts of F. race-
mosa leaves, and a value of >5 g/kg bw for the aqueous 
extract. All these observations regard various parts of 
F. racemosa (plant particularly) bark less toxic and safe 
for possible human consumption in order to derive its 
diverse heath benefits.
Conclusions
The study of herbal medicine spans the breadth of 
pharmacology including the study of the history, 
source, physical, and chemical properties, mecha-
nisms of action, absorption, distribution, biotransfor-
mation, excretion and therapeutic uses of “drugs”. In 
many respects, the pharmacological investigation of 
herbal medicine is just beginning. This review leaves 
no doubt that F. racemosa, a versatile medicinal plant, 
is investigated for many biological activities. Quite a 
significant amount of research has already been carried 
out during the past few decades in exploring the phyto-
chemistry and biological activities of different parts of 
F. racemosa. F. racemosa is a unique source of various 
types of compounds having diverse chemical structures. 
Very little work has been done on the biological activity 
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and plausible medicinal applications of these com-
pounds and hence extensive investigation is needed to 
exploit their therapeutic utility to combat diseases. The 
aqueous extract has also been marketed, which gen-
erates enough encouragement among the scientists 
in exploring more information about this medicinal 
plant in order to exploit its commercial potential. An 
extensive research and development work should be 
undertaken on F. racemosa for its better economic and 
therapeutic utilization.
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